SPA
ASTH icon

Sherbrooke Park Advisers’s Astrana Health ASTH Stock Holding History

Sherbrooke Park Advisers’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,666
Closed -$494K – 979
2024
Q4 		$494K Buy
+15,666
New +$744K 0.16% 219

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sherbrooke Park Advisers's ASTH Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Astrana Health (ASTH) in Q1 2025, closing a stake of 15,666 shares — an estimated $494K sold.

Sherbrooke Park Advisers first reported a position in ASTH in Q4 2024 and held it in 1 quarter. The position peaked at $494K in Q4 2024. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Astrana Health position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 15,666 Astrana Health shares in Q1 2025, an estimated $494K.
  • Sherbrooke Park Advisers first reported a position in Astrana Health in Q4 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Astrana Health position peaked at $494K in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.